Today's Daily Dose brings you news about FDA approval of Biohaven's migraine drug, iBio's Annual Meeting, Sangamo's deal with Biogen, and Zogenix's revised FDA decision date.
Read on…
Subscribe to continue reading the article.
This article is part of our premium content offering.Subscribe with a RTTNews subscription.
Subscribe NowAlready subscribed? Sign in
For comments and feedback: editorial@rttnews.com